References
- Pironi L, Arends J, Baxter J, et al. ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults. Clin Nutr. 2015 Apr;34(2):171–180.
- Jeppesen PB. Short bowel syndrome – characterisation of an orphan condition with many phenotypes. Expert Opin Orphan Drugs. 2013 Jul 1;1(7):515–525.
- Tappenden KA. Pathophysiology of short bowel syndrome: considerations of resected and residual anatomy. JPEN J Parenter Enteral Nutr. 2014 May;38(1 Suppl):14S–22S.
- Joly F, Baxter J, Staun M, et al. Five-year survival and causes of death in patients on home parenteral nutrition for severe chronic and benign intestinal failure. Clin Nutr. 2018 Aug;37(4):1415–1422.
- Tappenden KA. Intestinal adaptation following resection. JPEN J Parenter Enteral Nutr. 2014 May;38(1 Suppl):23S–31S.
- Mayeur C, Gillard L, Le Beyec J, et al. Extensive intestinal resection triggers behavioral adaptation, intestinal remodeling and microbiota transition in short bowel syndrome. Microorganisms. 2016 Mar;4(1):pii:E16. doi:10.3390/microroganisms4010016.
- Crenn P, Coudray-Lucas C, Thuillier F, et al. Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans. Gastroenterology. 2000 Dec;119(6):1496–1505.
- Crenn P, Morin MC, Joly F, et al. Net digestive absorption and adaptive hyperphagia in adult short bowel patients. Gut. 2004 Sep;53(9):1279–1286.
- Messing B, Crenn P, Beau P, et al. Long-term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome. Gastroenterology. 1999 Nov;117(5):1043–1050.
- Gillard L, Mayeur C, Robert V, et al. Microbiota is involved in post-resection adaptation in humans with short bowel syndrome. Front Physiol. 2017;8:224.
- Amiot A, Messing B, Corcos O, et al. Determinants of home parenteral nutrition dependence and survival of 268 patients with non-malignant short bowel syndrome. Clin Nutr. 2013 Jun;32(3):368–374.
- Tappenden KA, Thomson AB, Wild GE, et al. Short-chain fatty acids increase proglucagon and ornithine decarboxylase messenger RNAs after intestinal resection in rats. JPEN J Parenter Enteral Nutr. 1996 Oct;20(5):357–362.
- Joly F, Mayeur C, Messing B, et al. Morphological adaptation with preserved proliferation/transporter content in the colon of patients with short bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2009 Jul;297(1):G116–123.
- Mayeur C, Gratadoux -J-J, Bridonneau C, et al. Faecal D/L lactate ratio is a metabolic signature of microbiota imbalance in patients with short bowel syndrome. PLoS ONE. 2013;8(1):e54335.
- Pironi L, Arends J, Bozzetti F, et al. ESPEN guidelines on chronic intestinal failure in adults. Clin Nutr. 2016 Apr;35(2):247–307.
- Wang C, Venick RS, Shew SB, et al. Long-term outcomes in children with intestinal failure-associated liver disease treated with 6 months of intravenous fish oil followed by resumption of intravenous soybean oil. JPEN J Parenter Enteral Nutr. 2018 Nov 8. doi:10.1002/jpen.1463. [Epub ahead of print].
- Cazals-Hatem D, Billiauws L, Rautou P-E, et al. Ultra-short bowel is an independent risk factor for liver fibrosis in adults with home parenteral nutrition. Liver Int. 2018;38(1):174–182.
- Jeppesen PB. Spectrum of short bowel syndrome in adults: intestinal insufficiency to intestinal failure. JPEN J Parenter Enteral Nutr. 2014 May;38(1Suppl):8S–13S.
- Pape U-F, Maasberg S, Pascher A. Pharmacological strategies to enhance adaptation in intestinal failure. Curr Opin Organ Transplant. 2016 Apr;21(2):147–152.
- Jeppesen PB, Sanguinetti EL, Buchman A, et al. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients. Gut. 2005 Sep;54(9):1224–1231.
- Pb J, Pertkiewicz M, Messing B, et al. Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure. Gastroenterology. 2012 Dec;143(6):1473–1481.e3.
- Schwartz LK, O’Keefe SJD, Fujioka K, et al. Long-term teduglutide for the treatment of patients with intestinal failure associated with short bowel syndrome. Clin Transl Gastroenterol. 2016;7:e142.
- Jeppesen PB, Gabe SM, Seidner DL, et al. Factors associated with response to teduglutide in patients with short-bowel syndrome and intestinal failure. Gastroenterology. 2018;154(4):874–885.
- Seidner DL, Fujioka K, Boullata JI, et al. Reduction of parenteral nutrition and hydration support and safety with long-term teduglutide treatment in patients with short bowel syndrome-associated intestinal failure: STEPS-3 study. Nutr Clin Pract. 2018 Aug;33(4):520–527.
- Billiauws L, Bataille J, Boehm V, et al. Teduglutide for treatment of adult patients with short bowel syndrome. Expert Opin Biol Ther. 2017 May;17(5):623–632.
- Ring LL, Nerup N, Jeppesen PB, et al. Glucagon like peptide-2 and neoplasia; a systematic review. Expert Rev Gastroenterol Hepatol. 2018 Mar;12(3):257–264.
- Degn KB, Juhl CB, Sturis J, et al. One week’s treatment with the long-acting glucagon-like peptide 1 derivative liraglutide (NN2211) markedly improves 24-h glycemia and alpha- and beta-cell function and reduces endogenous glucose release in patients with type 2 diabetes. Diabetes. 2004 May;53(5):1187–1194.
- Madsen KB, Askov-Hansen C, Naimi RM, et al. Acute effects of continuous infusions of glucagon-like peptide (GLP)-1, GLP-2 and the combination (GLP-1+GLP-2) on intestinal absorption in short bowel syndrome (SBS) patients. A placebo-controlled study. Regul Pept. 2013;184:30–39.
- Hvistendahl M, Brandt CF, Tribler S, et al. Effect of liraglutide treatment on jejunostomy output in patients with short bowel syndrome: an open-label pilot study. JPEN J Parenter Enteral Nutr. 2018 Jan;42(1):112–121.
- Wismann P, Pedersen SL, Hansen G, et al. Novel GLP-1/GLP-2 co-agonists display marked effects on gut volume and improves glycemic control in mice. Physiol Behav. 2018;192:72–81.
- Scolapio JS, Camilleri M, Fleming CR. Gastrointestinal motility considerations in patients with short-bowel syndrome. Dig Dis. 1997 Oct;15(4–5):253–262.
- Szkudlarek J, Jeppesen PB, Mortensen PB. Effect of high dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients: a randomised, double blind, crossover, placebo controlled study. Gut. 2000 Aug;47(2):199–205.
- Jeppesen PB, Szkudlarek J, Høy CE, et al. Effect of high-dose growth hormone and glutamine on body composition, urine creatinine excretion, fatty acid absorption, and essential fatty acids status in short bowel patients: a randomized, double-blind, crossover, placebo-controlled study. Scand J Gastroenterol. 2001 Jan;36(1):48–54.
- Seguy D, Vahedi K, Kapel N, et al. Low-dose growth hormone in adult home parenteral nutrition-dependent short bowel syndrome patients: a positive study. Gastroenterology. 2003 Feb;124(2):293–302.
- Byrne TA, Wilmore DW, Iyer K, et al. Growth hormone, glutamine, and an optimal diet reduces parenteral nutrition in patients with short bowel syndrome: a prospective, randomized, placebo-controlled, double-blind clinical trial. Ann Surg. 2005 Nov;242(5):655–661.
- Wales PW, Nasr A, de Silva N, et al. Human growth hormone and glutamine for patients with short bowel syndrome. Cochrane Database Syst Rev. 2010 Jun;6:CD006321.
- Seguy D, Darmaun D, Duhamel A, et al. Growth hormone enhances fat-free mass and glutamine availability in patients with short-bowel syndrome: an ancillary double-blind, randomized crossover study. Am J Clin Nutr. 2014 Sep;100(3):850–858.
- Pironi L, Arends J, Bozzetti F, et al. ESPEN guidelines on chronic intestinal failure in adults. Clin Nutr. 2016 Apr;35(2):247–307.
- Thompson J, Sudan D. Intestinal lengthening for short bowel syndrome. Adv Surg. 2008;42:49–61.
- Bianchi A. From the cradle to enteral autonomy: the role of autologous gastrointestinal reconstruction. Gastroenterology. 2006 Feb;130(2 Suppl 1):S138–146.
- Kim HB, Fauza D, Garza J, et al. Serial transverse enteroplasty (STEP): a novel bowel lengthening procedure. J Pediatr Surg. 2003 Mar;38(3):425–429.
- Beyer-Berjot L, Joly F, Maggiori L, et al. Segmental reversal of the small bowel can end permanent parenteral nutrition dependency: an experience of 38 adults with short bowel syndrome. Ann Surg. 2012 Nov;256(5):739–744. discussion 744–745.
- Grant D, Abu-Elmagd K, Mazariegos G, et al. Intestinal transplant registry report: global activity and trends. Am J Transplant. 2015 Jan;15(1):210–219.